Anavex Life Sciences Corp. (AVXL)

5.09 +0.06 (+1.19%) USD  |  NASDAQ  |  Jan 21, 11:16
More

Anavex Life Sciences Net Total Long Term Debt (Quarterly)

Net Total Long Term Debt (Quarterly) Chart

View Net Total Long Term Debt (Quarterly) for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Total Long Term Debt (Quarterly) Range, Past 5 Years

View Net Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Total Long Term Debt (Quarterly) Benchmarks

View Net Total Long Term Debt (Quarterly) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Ocugen, Inc. Upgrade
AnaptysBio, Inc. Upgrade
Replimune Group, Inc. Upgrade